ATE539066T1 - COMPOUNDS CONTAINING ORGANOSELS AND THEIR USE - Google Patents

COMPOUNDS CONTAINING ORGANOSELS AND THEIR USE

Info

Publication number
ATE539066T1
ATE539066T1 AT05822319T AT05822319T ATE539066T1 AT E539066 T1 ATE539066 T1 AT E539066T1 AT 05822319 T AT05822319 T AT 05822319T AT 05822319 T AT05822319 T AT 05822319T AT E539066 T1 ATE539066 T1 AT E539066T1
Authority
AT
Austria
Prior art keywords
organosels
compounds containing
compound
present
organoselenium
Prior art date
Application number
AT05822319T
Other languages
German (de)
Inventor
Jungyeob Ham
Jaeyoung Ko
Hoosang Hwang
Original Assignee
Seoul Nat Univ Ind Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seoul Nat Univ Ind Foundation filed Critical Seoul Nat Univ Ind Foundation
Priority claimed from PCT/KR2005/004685 external-priority patent/WO2006071103A1/en
Application granted granted Critical
Publication of ATE539066T1 publication Critical patent/ATE539066T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00—Racemisation; Complete or partial inversion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to an organoselenium compound, a preparation method thereof and a medical composition comprising the compound as active ingredient. The organoselenium compound of the present invention has activity for peroxisome proliferator activated receptor d (PPARd ) .
AT05822319T 2004-12-31 2005-12-30 COMPOUNDS CONTAINING ORGANOSELS AND THEIR USE ATE539066T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20040118109 2004-12-31
PCT/KR2005/004685 WO2006071103A1 (en) 2004-12-31 2005-12-30 Organoselenium containing compounds and their use
KR1020050135761A KR100753860B1 (en) 2004-12-31 2005-12-30 Organoselenium containing compounds and their use

Publications (1)

Publication Number Publication Date
ATE539066T1 true ATE539066T1 (en) 2012-01-15

Family

ID=37170880

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05822319T ATE539066T1 (en) 2004-12-31 2005-12-30 COMPOUNDS CONTAINING ORGANOSELS AND THEIR USE

Country Status (4)

Country Link
KR (1) KR100753860B1 (en)
CN (1) CN101146783B (en)
AT (1) ATE539066T1 (en)
ES (1) ES2379800T3 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2013114390A (en) * 2010-08-31 2014-10-10 СНУ Ар энд ДиБи ФАУНДЕЙШН APPLICATION OF FETAL REPROGRAMMING BY PPAR-DELTA-AGONIST
CN104520269A (en) * 2012-09-28 2015-04-15 住友精化株式会社 Method for producing selenol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE451346T1 (en) * 1998-03-10 2009-12-15 Ono Pharmaceutical Co CARBOXYLIC ACID DERIVATIVES AND MEDICATIONS THAT CONTAIN THEM AS THE ACTIVE INGREDIENTS
GB9914977D0 (en) * 1999-06-25 1999-08-25 Glaxo Group Ltd Chemical compounds
KR100474202B1 (en) * 2002-05-04 2005-03-08 강헌중 Process for preparing thiazol derivative and the intermediate compounds for preparing the same
KR100691375B1 (en) * 2004-02-03 2007-03-09 재단법인서울대학교산학협력재단 Process for preparing ligands of ppar? and the intermediate compounds for preparing the same

Also Published As

Publication number Publication date
KR20060079134A (en) 2006-07-05
CN101146783A (en) 2008-03-19
KR100753860B1 (en) 2007-08-31
CN101146783B (en) 2011-02-02
ES2379800T3 (en) 2012-05-03

Similar Documents

Publication Publication Date Title
NO20063517L (en) New crystalline form v of agomelatine, process for its preparation and pharmaceutical compositions containing the
BR0306870A (en) Oral pharmaceutical composition and method for preparing the same
MX2007011009A (en) Organic compounds.
NO20063516L (en) New crystalline form III of agomelatine, process for its preparation and pharmaceutical compositions containing the
NO20060947L (en) β d-crystalline form of ivabradine hydrochloride, process for its preparation and pharmaceutical compositions containing the
TW200738698A (en) Organic compounds
NO20064596L (en) Delta crystalline form of ivabradine hydrochloride, process for its preparation and pharmaceutical compositions containing the
GEP20115359B (en) Fused cyclic compounds
UA106199C2 (en) Aminobenzamide derivatives as agents suitable for controlling animal parasites
BRPI0414581C1 (en) compound, pharmaceutical composition comprising said compound and use of said compound
NO20070224L (en) 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
MX2008000255A (en) Urea glucokinase activators.
UA86595C2 (en) Gamma-crystalline form of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
SI1843754T1 (en) New pharmaceutical composition containing candesartan cilexetil as lipophilic crystalline substance
DE602005014341D1 (en) BENZIMIDAZOL SUBSTITUTED THIOPHENE DERIVATIVES ACTING ON IKK3
TW200626158A (en) Naphthaline derivatives
ATE482192T1 (en) PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF RENIN ACTIVITY-DEPENDENT DISEASE
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
SE0301701D0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0402635D0 (en) Chemical compounds
SE0301699D0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW200634002A (en) Chemical compounds
AR056369A1 (en) COMPOUNDS DERIVED FROM QUINAZOLINE AND PHARMACEUTICAL COMPOSITION
EA200870223A1 (en) DERIVATIVES OF BENZOIZOINDOL FOR THE TREATMENT OF PAIN
ATE539066T1 (en) COMPOUNDS CONTAINING ORGANOSELS AND THEIR USE